Show simple item record

dc.contributor.authorVorkamp, Katrin
dc.contributor.authorCastaño, Argelia
dc.contributor.authorAntignac, Jean-Philippe
dc.contributor.authorBoada, Luis D.
dc.contributor.authorCequier Manciñeiras, Enrique
dc.contributor.authorCovaci, Adrian
dc.contributor.authorEsteban López, Marta
dc.contributor.authorHaug, Line S.
dc.contributor.authorKasper-Sonnenberg, Monika
dc.contributor.authorKoch, Holger M.
dc.contributor.authorPérez Luzardo, Octavio Luis
dc.contributor.authorOsīte, Agnese
dc.contributor.authorRambaud, Loïc
dc.contributor.authorPinorini, Maria-Teresa
dc.contributor.authorSabbioni, Gabriele
dc.contributor.authorThomsen, Cathrine
dc.date.accessioned2021-01-21T13:36:30Z
dc.date.available2021-01-21T13:36:30Z
dc.date.issued2020-11-20
dc.identifier.issn0160-4120
dc.identifier.urihttp://hdl.handle.net/10459.1/70293
dc.description.abstractThe major purpose of human biomonitoring is the mapping and assessment of human exposure to chemicals. The European initiative HBM4EU has prioritized seven substance groups and two metals relevant for human exposure: Phthalates and substitutes (1,2-cyclohexane dicarboxylic acid diisononyl ester, DINCH), bisphenols, per- and polyfluoroalkyl substances (PFASs), halogenated and organophosphorous flame retardants (HFRs and OPFRs), polycyclic aromatic hydrocarbons (PAHs), arylamines, cadmium and chromium. As a first step towards comparable European-wide data, the most suitable biomarkers, human matrices and analytical methods for each substance group or metal were selected from the scientific literature, based on a set of selection criteria. The biomarkers included parent compounds of PFASs and HFRs in serum, of bisphenols and arylamines in urine, metabolites of phthalates, DINCH, OPFRs and PAHs in urine as well as metals in blood and urine, with a preference to measure Cr in erythrocytes representing Cr (VI) exposure. High performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was the method of choice for bisphenols, PFASs, the HFR hexabromocyclododecane (HBCDD), phenolic HFRs as well as the metabolites of phthalates, DINCH, OPFRs and PAHs in urine. Gas chromatographic (GC) methods were selected for the remaining compounds, e.g. GC-low resolution MS with electron capture negative ionization (ECNI) for HFRs. Both GC–MS and LC-MS/MS were suitable for arylamines. New developments towards increased applications of GC–MS/MS may offer alternatives to GC–MS or LC-MS/MS approaches, e.g. for bisphenols. The metals were best determined by inductively coupled plasma (ICP)-MS, with the particular challenge of avoiding interferences in the Cd determination in urine. The evaluation process revealed research needs towards higher sensitivity and non-invasive sampling as well as a need for more stringent quality assurance/quality control applications and assessments.ca_ES
dc.description.sponsorshipThis study was part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733032.ca_ES
dc.language.isoengca_ES
dc.publisherElsevierca_ES
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.envint.2020.106082ca_ES
dc.relation.ispartofEnvironment International, 2021, vol. 146, p. 106082ca_ES
dc.rightscc-by-nc-nd, (c) Elsevier, 2020ca_ES
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBisphenolsca_ES
dc.subjectFlame retardantsca_ES
dc.subjectMetalsca_ES
dc.subjectPer- and polyfluoroalkyl substancesca_ES
dc.subjectPhthalatesca_ES
dc.titleBiomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiativeca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.identifier.idgrec030926
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.1016/j.envint.2020.106082
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/733032/EU/HBM4EUca_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by-nc-nd, (c) Elsevier, 2020
Except where otherwise noted, this item's license is described as cc-by-nc-nd, (c) Elsevier, 2020